Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro Signaling and cellular microbiology

BMC Microbiology

Volumn 15, Issue 1, 2015, Pages

  Leal, Angélica Maria De Sousa ^a   De Queiroz, Jana Dara Freires ^a   De Medeiros, Silvia Regina Batistuzzo ^a   Lima, Tatjana Keesen De Souza ^b   Agnez Lima, Lucymara Fassarella ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Chromobacterium violaceum; Cytotoxicity; Mitochondrial membrane potential; Oxidative stress; Violacein

Indexed keywords

ANTIOXIDANT; PIGMENT; UNCLASSIFIED DRUG; VIOLACEIN; INDOLE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL LINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SENSITIVITY; FEMALE; FETUS; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; ANIMAL; CELL SURVIVAL; CHO CELL LINE; CRICETULUS; DRUG EFFECTS; HELA CELL LINE; METABOLISM;

CHROMOBACTERIUM VIOLACEUM;

ANIMALS; CELL DEATH; CELL LINE; CELL SURVIVAL; CHO CELLS; CRICETULUS; HELA CELLS; HUMANS; INDOLES; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 85002484129     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-015-0452-2     Document Type: Article

References (35)

1. Subramaniam S, Ravi V, Sivasubramanian A. Synergistic antimicrobial profiling of violacein with commercial antibiotics against pathogenic micro-organisms. Pharm Biol. 2014;52:86-90.
2. Cazoto LL, Martins D, Ribeiro MG, Durán N, Nakazato G. Antibacterial activity of violacein against Staphylococcus aureus isolated from bovine mastitis. J Antibiot (Tokyo). 2011;64:395-7.
3. Berni E, Marcato PD, Nakazato G, Kobayashi RKT, Vacchi FI, Umbuzeiro GA, et al. Violacein/poly(ε-caprolactone)/chitosan nanoparticles against bovine mastitis: Antibacterial and ecotoxicity evaluation. J Phys: ConfSer. 2013;429:012030.
4. Melo PS, Maria SS, Vidal BC, Haun M, Durán N. Violacein cytotoxicity and induction of apoptosis in V79 cells. In Vitro Cell Dev Biol Anim. 2000;36:539-43.
5. Bromberg N, Dreyfuss JL, Regatieri CV, Palladino MV, Durán N, Nader HB, et al. Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem Biol Interact. 2010;186:43-52.
6. Queiroz KC, Milani R, Ruela-de-Sousa RR, Fuhler GM, Justo GZ, Zambuzzi WF, et al. Violacein induces deathof resistant leukaemia cells via kinome reprogramming, endoplasmic reticulumstress and Golgi apparatus collapse. PLoS One. 2012;7:e45362.
7. Leon LL, Miranda CC, De Souza AO, Durán N. Antileishmanial activity of the violacein extracted from Chromobacteriumviolaceum. J Antimicrob Chemother. 2001;48:449-50.
8. May G, Brummer B, Ott H. Treatment of prophylaxis of polio and herpes virus infections comprises admin. of 3-(1,2-dihydro-5-(5-hydroxy-1H- indol-3-yl)-2-oxo-3H-pyrrole-3-ylidene)-1,3-dihydro-2H-indol-2-one.∈GerOffenDE 1991, 3935066.
9. Andrighetti-Fröhner CR, Antonio RV, Creczynski-Pasa TB, Barardi CR, Simões CM. Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacteriumviolaceum. Mem Inst Oswaldo Cruz. 2003;98:843-8.
10. Durán N, Antonio RV, Haun M, Pilli RA. Biosynthesis of a trypanocide by Chromobacteriumviolaceum. World J Microbiol Biotechno. 1994;10:686-90.
11. Matz C, Webb JS, Schupp PJ, Phang SY, Penesyan A, Egan S, et al. Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS One. 2008;3:e2744.
12. Lopes SC, Blanco YC, Justo GZ, Nogueira PA, Rodrigues FL, Goelnitz U, et al. Violacein extracted from Chromobacteriumviolaceum inhibits Plasmodium growth in vitro and in vivo. Antimicrob Agents Chemother. 2009;53:2149-52.
13. Antonisamy P, Ignacimuthu S. Immunomodulatory, analgesic and antipyretic effects of violacein isolated from Chromobacteriumviolaceum. Phytomedicine. 2010;17:300-4.
14. Antonisamy P, Kannan P, Ignacimuthu S. Anti-diarrhoeal and ulcer-protective effects of violacein isolated from Chromobacteriumviolaceum in Wistar rats. Fundam Clin Pharmacol. 2009;23:483-90.
15. Konzen M, De Marco D, Cordova CA, Vieira TO, Antônio RV, Creczynski-Pasa TB. Antioxidant properties of violacein: possible relation on its biological function. Bioorg Med Chem. 2006;14:8307-13.
16. de Carvalho DD, Costa FT, Duran N, Haun M. Cytotoxic activity of violacein in human colon cancer cells. Toxicol In Vitro. 2006;20:1514-21.
17. Arur S, Uche UE, Rezaul K, Fong M, Scranton V, Cowan AE, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell. 2003;4:587-98.
18. Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z. Apoptosis and beyond: cytometry in studies of programmed cell death. Methods Cell Biol. 2011;103:55-98.
19. Bromberg N, Justo GZ, Haun M, Durán N, Ferreira CV. Violacein cytotoxicity on human blood lymphocytes and effect on phosphatases. J Enzyme Inhib Med Chem. 2005;20:449-54.
20. Saraiva VS, Marshall JC, Cools-Lartigue J, Burnier Jr MN. Cytotoxic effects of violacein in human uveal melanoma cell lines. Melanoma Res. 2004;14:421-4.
21. Matés JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 2000;153:83-104.
22. Franco-Molina MA, Mendoza-Gamboa E, Sierra-Rivera CA, Gómez-Flores RA, Zapata-Benavides P, Castillo-Tello P, et al. Antitumor activity of colloidal silver on MCF-7 human breast cancer cells. J Exp Clin Cancer Res. 2010;29:148.
23. Mojib N, Nasti TH, Andersen DT, Attigada VR, Hoover RB, Yusuf N, et al. The antiproliferative function of violacein-like purple violet pigment (PVP) from an Antarctic Janthinobacterium sp. Ant5-2 in UV-induced 2237 fibrosarcoma. Int J Dermatol. 2011;50:1223-33.
24. Melo PS, de Azevedo MM, Frungillo L, Anazetti MC, Marcato PD, Durán N. Nanocytotoxicity: violacein and violacein-loaded poly (D, L-lactide-co-glycolide) nanoparticles acting on human leukemic cells. J Biomed Nanotechnol. 2009;5:192-201.
25. Ferreira CV, Bos CL, Versteeg HH, Justo GZ, Durán N, Peppelenbosch MP. Molecular mechanism of violacein-mediated human leukemia cell death. Blood. 2004;104:1459-64.
26. Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m))in apoptosis; an update. Apoptosis. 2003;8:115-28.
27. Perl A, Gergely Jr P, Nagy G, Koncz A, Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 2004;25:360-7.
28. Banki K, Hutter E, Gonchoroff NJ, Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fassignaling. J Immunol. 1999;162(3):1466-79.
29. VandenBerghe T, Vanlangenakker N, Parthoens E, Deckers W, Devos M, Festjens N, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ. 2010;6:922-30.
30. Rettori D, Duran N. Production, extraction and purificationof violacein: an antibiotic pigment producedby Chromobacteriumviolaceum. World J Microbiol Biotechnol. 1998;14:685-8.
31. Kaltenbach JP, Kaltenbach MH, Lyons WB. Nigrosin as a dye for differentiating live and dead ascites cells. Exp Cell Res. 1958;15:112-7.
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
33. Petta TB, Nakajima S, Zlatanou A, Despras E, Couve-Privat S, Ishchenko A, et al. Human DNA polymerase iota protects cells against oxidative stress. EMBO J. 2008;27:2883-95.
34. Hawkins CL, Morgan PE, Davies MJ. Quantification of protein modification by oxidants. Free Radic Biol Med. 2009;46:965-88.
35. Li JJ, Tang Q, Li Y, Hu BR, Ming ZY, Fu Q, et al. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol Sin. 2006;27:1078-84.